Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.165
-0.18
(-7.87%)
USD |
NASDAQ |
Nov 13, 11:23
Bridgebio Oncology Therapeutics Net Income (Annual) : -134.04M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -134.04M |
| December 31, 2024 | -74.28M |
| December 31, 2023 | -0.0417M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.0035M |
| December 31, 2021 | -0.0434M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Korsana Biosciences, Inc. | -3.528M |
| IRulya Therapeutics, Inc. | -83.98M |
| PepGen Inc. | -89.66M |
| Q32 Bio, Inc. | 29.82M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |